Multidrug Resistance Among Enterococci at a Tertiary Care Hospital in Northern Bulgaria

1. Leclercq R. Enterococci acquire new kinds of resistance. Clin Infect Dis. I997;24(l):580-1.Search in Google Scholar

2. Murray BE. The life and times of the Enterococcus. Gin Microbiol Rev. 1990;3:46-65.10.1128/CMR.3.1.46Search in Google Scholar

3. Werner G, GoqucTM, Hammerum AM, Hope R, Hrynicwicz W, Johnson A, ct al Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Survcill. 2008; 3 (47)pii 19046.10.2807/ese.13.47.19046-enSearch in Google Scholar

4. Willems RJ, Bonten MJ. Glyoopcptidc-resistant enterococci: deciphering virulence, resistance and cpidcmicity. Cutt Opin Infect Dis. 2007;20:384-90.10.1097/QCO.0b013e32818be63dSearch in Google Scholar

5. Willems RJ, Homan W, Top J.van Santten M, Tribe D, Manzioros X, ct al. Variantt?\pgcncasa marker of a distinct genetic lineage of vancomycin-resistant Entemcoccus faecium spreading in hospitals. Lancet 2001 ;357:853-5.10.1016/S0140-6736(00)04205-7Search in Google Scholar

6. Willems RJ, Top J, Van Santrn M, Robinson DA, Coquc TM, Baqucro F, ct al. Global spread of vancomycin-resistant Enterococcusfaecium from distinct nosocomial genetic complex. Emcrg Infect Dis. 2005;11:821-8.10.3201/1106.041204Search in Google Scholar

7. Leavis HL, Bonten MJ, Willems RJ. Identification ofhigh-risk cntrocoocal clonal complexes: global dispersion and antibiotic resistance. Girr Opin Microbiol. 2006,9:454-60.10.1016/j.mib.2006.07.001Search in Google Scholar

8. Huyekc M, Sahm D, Gilmore S. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emcrg Infect Dis. 1998;4:1218-31.Search in Google Scholar

9. Keuleyan E, Srodkova M, Stefaniov I, Savov E, Borissova V, Markovska Ret al Survey on antimicrobial resistance in enterococci from human and vctcrinaiy sources. Proceedings of the XXXIII Annual Conference of Indian Pharmacological Society; 2000 December 28-30; Gandhinagar; India.Search in Google Scholar

10. Lazarova G, Kantardjiev T, Velinov C, Rachkova K, Rukanova D, Dukova Let al. Vancomycin-resistant enterococci in hospitalized patients with urinary tract infections - first report in Bulgaria. TrakiaJ Sci.2005;3{4):13-4.Search in Google Scholar

11. Facklam RR, CoDins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol. 1989;27(4):731-410.1128/jcm.27.4.731-734.1989Search in Google Scholar

12. Devriese LA, Pot B, Kersters K, Lauwers S, Haesebrouck F. Acidification of methyl-a-D-ghioopiranosid: a useful test to differentiate Enterococcus cassehjlavus and Enterococcus Call inarum from Enterococcus faecium spoc ics.group and from Enterococcus faecalis. J Gin Microbiol. 1996;34(IO):2607-8.10.1128/jcm.34.10.2607-2608.1996Search in Google Scholar

13. Enterococcus spp. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement MI00-S22. Ginical and Laboratory Standards Institute. 2012;32(3):90-4.Search in Google Scholar

14. Barisic Z, Punda-Polic V. Antibiotic resistance among cntcrocoocal strains isolated from clinical specimens. Int J Antimicrob Agents. 2000; 16(1)65-8.10.1016/S0924-8579(00)00197-7Search in Google Scholar

15. Sader HS, Moet GJ, Jones RN. Update on the in vitro activity ofdaptomyein tested against 17,193 Gram-positive bacteria isolated from European Medical Centers (2005-2007). J Chcmothcr. 2009;2l(5):500-6.10.1179/joc.2009.21.5.50019933040Search in Google Scholar

16. Zouain MG, Araj GF. Antimiaobial resistance of enterococci in Lebanon. Int J Antimicrob AgenU. 2001;17(3):209-13.10.1016/S0924-8579(00)00347-2Search in Google Scholar

17. Entcrocooci. Annual report of the European Antimiaobial Resistance Surveillance Network. (EARS-Net). Stockholm, ECDC, 2010. p. 33-7.Search in Google Scholar

18. Aznar J, Lepe JA, Dowacky M. Antimiaobial susceptibility among £ faecal is and £. faecaim from France, Germany, Italy, Spain and the UK (T.E.S.T. Surveillance Study,2004-2009) J Chcmothcr. 20l2;24(2):74-80.10.1179/1120009X12Z.0000000001622546761Search in Google Scholar

19. Torell E, Cars O, Olsson-LijcquistB, Hoffman B, Lindback J, Butman LG and The Entaoooccal Study Group. Near absence of vancomycin-resistant enterococci but high catTbge rates of quinoloncs-rcsistant ampicillin-rcsistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden. J Clin Microbiol. 1999;37:3509-13.10.1128/JCM.37.11.3509-3513.19998568010523543Search in Google Scholar

20. Torell E, Cars O, Hambracus A. Ampicillin-rcsistant enterococci in a Swedish University Ho<pital; nosocomial spread and risk-factors for infection. ScandJ Infect Dis. 2001;33: 182-7.10.1080/0036554015106078911303807Search in Google Scholar

21. Leavis HL, Willems RJ.Top J, Bonten MJ. High-level ciprofloxacin resistance from point mutations in gyrA and parC oonfinod to global hospital-adapted clonal lineage CCI7 of Enterococcusfaeciunt J Clin Microbiol. 2006;44: 1059-64.Search in Google Scholar

22. Torell E, Kuhn I, Olsson-Lijequist B, Haeggman S, Hoffman B-M, Lindahl C, Burman LG. Clonality among ampicillin-rcsistant Enterococcus faecium isolates in Sweden and relationship with ciprofloxacin resistance. Clin Miaobiol Infect. 2003;9; 1011-9.10.1046/j.1469-0691.2003.00701.x14616743Search in Google Scholar

23. Shoutcn MA, Moss A, Hoogkamp-Korstanjc JA. Antimicrobial susceptibility patterns of cnterocooci causing infections in Europe. The European VRE Study Group. Antimicrob AgenU Chcmothcr. 1999;43:2542-6.Search in Google Scholar

24. Hallgren A, Abednazari H, Ekdahl C, Hanbenger H, Nilsson M, Samuelssona A, at al. Antimicrobial susceptibility patterns of cnterocooci in intensive care uniU in Sweden evaluated by diffaent MIC breakpoint systems. J AntimiaobChemolher. 2001 ;4 833-62.Search in Google Scholar

25. Sredkova M. Resistance to penicillins, aminoglycosides and vancomycin in cnterocooci isolated from clinical specimens. Infoctology. 1999,36(2): 18-21. [In Bulgarian], Search in Google Scholar

26. Thapa B, Tattawasart U, Manjai A, Chantarasuk Y. Antimiaobial resistance and species prevalence of cterocoocal isolates in Srinagarind Hospital, Northeastern Thailand KKU Res J (GS). 20I2;7 (4):97-107.10.5481/KKUJGS.2007.07.4.11Search in Google Scholar

27. Butcu M, Akcay SS, Inan AS, Aksaray S, Engin IX), Calisid G. In vitro susceptibility of cnterocooci strains isolated from urine samples to fosfomycin and other antibiotics. J Infect Chcmothcr. 2011; 17(4):575-8.10.1007/s10156-011-0212-721287226Search in Google Scholar

28. Salem-Bekhit MM, Moussa L Muharram MM, Alanazy FK, Hefiti HM. Prevalence and antimiaobial resistance pattern of multidrug-rcsistant cntrcrococci isolated from clinical specimens. Indian J Med Microbiol. 2012;30( I );44-51.10.4103/0255-0857.9303222361760Search in Google Scholar

29. Frazzon A, Gama BA, Hames V, Bierhals CG, Pereira RL Gucdcs AG ct al. Prevalence of antimicrobial resistance and molecular characterization of tetracycline resistance mediated by ref (M) and let (L) genes in Enterococcus spp. isolated from food in Southan Brasil. World J Microbiol Biotochnol. 2010; 26; 365-70.10.1007/s11274-009-0160-xSearch in Google Scholar

30. Quinones D, Goni P, Rubio MC, Duran E, Gomez-Lus R. Enterococcus spp. isolated from Cuba; species frequency of occurrence and antimicrobial susceptibility profile. Diagn Microbiol Infect Dis. 2005;51(l):63-7.10.1016/j.diagmicrobio.2004.08.01815629231Search in Google Scholar

31. Zhanel GG, Hoban DJ, Karlowsky JA. Nitrofurantoin is active against vancomycin-resistant enterococci. Antimicrob Agents Chcmothcr. 2001 ;45( I ):324-6.10.1128/AAC.45.1.324-326.20019028411120989Search in Google Scholar